Mokhtar Mohamed, Tadokoro Yukiko, Nakagawa Misako, Morimoto Masami, Takechi Hirokazu, Kondo Kazuya, Tangoku Akira
Department of Oncological Medical Services, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto, Tokushima, 770-8505, Japan.
Department of Oncological Surgery, Minia Oncology Institute, Minya, 61111, Egypt.
Breast Cancer. 2016 Mar;23(2):202-10. doi: 10.1007/s12282-014-0551-1. Epub 2014 Jul 29.
Sentinel lymph node biopsy (SLNB) became a standard surgical procedure for patients with early breast cancer; however, the optimal method of sentinel lymph node (SLN) identification remains controversial. The current study presents the protocol of our institution for preoperative and intraoperative SLN detection.
Fifty female patients with early breast cancer and clinically node-negative axilla were enrolled in this study. All patients underwent preoperative CT lymphography (CTLG), intraoperative SLNB using fluorescence navigation, intraoperative one-step nucleic acid amplification (OSNA) and postoperative hematoxylin and eosin histopathological analysis. Prediction of metastasis by CTLG and detection of metastasis by OSNA were compared to results of histopathology as standard reference.
SLN were identified by preoperative CTLG and intraoperative SLNB with fluorescence navigation in all patients, the identification rate was 100 %. SLN metastases were detected as positive by OSNA in 9 patients (18 %), 4 were (++), 4 were (+) and 1 was (+I). SLN metastases were detected as positive by histopathology in 10 patients (20 %). The concordance rate between OSNA and permanent sections was 90 %. The negative predictive value of CTLG was 80 %.
Use of CTLG and fluorescence navigation made performing SLNB with high accuracy possible in institutions that cannot use the radioisotope method. OSNA provided accurate intraoperative method, allowing for completion of axillary node dissection during surgery and avoidance of second surgical procedure in patients with positive SLNs, thereby reducing patient distress and, finally, saving hospital costs.
前哨淋巴结活检(SLNB)已成为早期乳腺癌患者的标准外科手术;然而,前哨淋巴结(SLN)识别的最佳方法仍存在争议。本研究介绍了我们机构术前和术中检测SLN的方案。
本研究纳入了50例早期乳腺癌且临床腋窝淋巴结阴性的女性患者。所有患者均接受术前CT淋巴造影(CTLG)、术中荧光导航下的SLNB、术中一步核酸扩增(OSNA)以及术后苏木精-伊红组织病理学分析。将CTLG对转移的预测和OSNA对转移的检测与作为标准参考的组织病理学结果进行比较。
所有患者均通过术前CTLG和术中荧光导航下的SLNB识别出SLN,识别率为100%。OSNA检测出9例患者(18%)的SLN转移为阳性,4例为(++),4例为(+),1例为(+I)。组织病理学检测出10例患者(20%)的SLN转移为阳性。OSNA与永久切片之间的一致性率为90%。CTLG的阴性预测值为80%。
在无法使用放射性同位素方法的机构中,使用CTLG和荧光导航使得高精度地进行SLNB成为可能。OSNA提供了准确的术中方法,允许在手术期间完成腋窝淋巴结清扫,并避免对SLN阳性患者进行二次手术,从而减轻患者痛苦,并最终节省医院成本。